이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Poly Medicure 미래 성장
Future 기준 확인 5/6
Poly Medicure (는) 각각 연간 24.4% 및 19.7% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 24.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 21.4% 로 예상됩니다.
주요 정보
24.4%
수익 성장률
24.4%
EPS 성장률
| Medical Equipment 수익 성장 | 21.2% |
| 매출 성장률 | 19.7% |
| 향후 자기자본 수익률 | 21.4% |
| 애널리스트 커버리지 | Low |
| 마지막 업데이트 | 25 Jul 2024 |
최근 미래 성장 업데이트
Recent updates
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20
Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00
Sep 14After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar
Sep 06Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138
Jul 27Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)
Jul 11Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return
Mar 01I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease
Feb 16수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 3/31/2027 | 24,957 | 5,364 | 3,555 | N/A | 2 |
| 3/31/2026 | 20,826 | 4,336 | 2,049 | N/A | 5 |
| 3/31/2025 | 16,979 | 3,359 | 929 | N/A | 5 |
| 6/30/2024 | 14,397 | 2,696 | N/A | N/A | N/A |
| 3/31/2024 | 13,758 | 2,583 | -109 | 2,661 | N/A |
| 12/31/2023 | 13,046 | 2,487 | N/A | N/A | N/A |
| 9/30/2023 | 12,498 | 2,337 | -197 | 2,390 | N/A |
| 6/30/2023 | 11,872 | 2,150 | N/A | N/A | N/A |
| 3/31/2023 | 11,152 | 1,793 | -482 | 1,911 | N/A |
| 12/31/2022 | 10,659 | 1,566 | N/A | N/A | N/A |
| 9/30/2022 | 10,113 | 1,411 | -533 | 1,568 | N/A |
| 6/30/2022 | 9,600 | 1,359 | N/A | N/A | N/A |
| 3/31/2022 | 9,231 | 1,465 | -321 | 1,235 | N/A |
| 12/31/2021 | 8,785 | 1,492 | N/A | N/A | N/A |
| 9/30/2021 | 8,518 | 1,500 | -228 | 777 | N/A |
| 6/30/2021 | 8,280 | 1,468 | N/A | N/A | N/A |
| 3/31/2021 | 7,865 | 1,359 | 236 | 1,187 | N/A |
| 12/31/2020 | 7,448 | 1,197 | N/A | N/A | N/A |
| 9/30/2020 | 7,218 | 1,094 | 347 | 1,543 | N/A |
| 6/30/2020 | 6,960 | 1,028 | N/A | N/A | N/A |
| 3/31/2020 | 6,872 | 959 | 223 | 1,283 | N/A |
| 12/31/2019 | 6,881 | 947 | N/A | N/A | N/A |
| 9/30/2019 | 6,625 | 858 | 603 | 1,197 | N/A |
| 6/30/2019 | 6,388 | 719 | N/A | N/A | N/A |
| 3/31/2019 | 6,108 | 654 | 285 | 1,065 | N/A |
| 3/31/2018 | 5,204 | 706 | N/A | 750 | N/A |
| 3/31/2017 | 4,550 | 551 | N/A | 561 | N/A |
| 3/31/2016 | 4,123 | 483 | N/A | 632 | N/A |
| 3/31/2015 | 3,903 | 623 | N/A | 633 | N/A |
| 3/31/2014 | 3,222 | 451 | N/A | 661 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: POLYMED 의 연간 예상 수익 증가율( 22.6% )이 saving rate( 6.7% 보다 높습니다. ).
수익 vs 시장: POLYMED 의 연간 수익( 22.6% ) Indian 시장( 15.9% 보다 빠르게 성장할 것으로 예상됩니다. 15.9% 연간).
고성장 수익: POLYMED 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.
수익 대 시장: POLYMED 의 수익(연간 18.8% ) Indian 시장( 9.5% 보다 빠르게 성장할 것으로 예상됩니다. 9.5% 연간).
고성장 수익: POLYMED 의 수익(연간 18.8% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: POLYMED 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 21.4 %)